Replies to post #26715 on Creative Medical Technology Holdings Inc (CELZ)

[LaFortuna]

Then all you explain to us why this has lost more than 75% since the 10 cent PPS predictions during the news breaking conference.

MM's short these types of stocks for a reason and one reason alone, because they KNOW it's crushing itself from the inside out.

We been reading Q's since 1982 and I would suggest you all read the latest Q and tell us maybe, just maybe this is going down to sub-penny very soon because of the countless toxic notes, clearly outlined in the Q which will be converting at a 60% discount and adding 100's of millions of shares to the float.

So, what we all have here is a double shotgun, shorting and diluting which is going to blow the PPS into sub-penny land very, very soon.

Prove us wrong, please as we are holding 655K shares at 024 and will take the tax loss in December (prefer we don't have too) to offset our gains in two other OTC stocks.

PROVE US WRONG, trust us we're NOT!

[CorruptionFighter]

Well stated UVA. I'm amazed that we can't go a day on this board without the sky falling or the heavens parting. This is going to take time to develop. We need patience and to look at things with both eyes open. A few positives:

1) It's positive news that CMTH/CELZ has hired an individual with medical/pharma background to lead the revenue generation of CaverStem.

2) It's positive that when I reached out to the COO yesterday, he responded within 2 hours regarding the article (hit piece) in EG. Donald Dickerson was on point in his reply yet displayed a strong level of professionalism you'd expect from someone with an MBA in Finance from USC and career as a CFO. He's not getting paid much in salary so he's in this for future benefits.

3) As you and others have stated multiple times, Thomas Ichim has built and sold other companies in the medical/bio-tech space for substantial profits before. He understands what it will take to get CaverStem and CMTH other patents to producing enough revenue to either entice a profitable buyout at some point, or to continue growing the revenue and executing the introduction of AmnioStem and other patent offerings and ultimately up listing the company. Either way, we win!

4) Timothy Warbington purchased in April almost 10M shares at $.0138 for approximately $140K. Why would the CEO pay $140K out of pocket when a) he didn't need to buy them and b) when he paid more than market price. I wouldn't do that to tank the stock. Makes NO sense. He has approximately 100M shares and wants to be rich, very rich! CMTH/CELZ he knows is his golden goose. He's not taking much salary ($10K/month) as he is planning for a much, much greater payday downstream.

Those are a few of the positives from my view. Are there issues getting everything accomplished, yes. Do we know that CMTH/CELZ is a homerun, no. If everything was assured, we wouldn't be in OTC looking for hidden gems.

Will the stock go up and down over the next month+.? Absolutely. However, these guys have been there and done that and are executing their plan well. They are all mature (50+) and have learned through trial and error what works and what it takes to be profitable and entice buyout suitors.

The final positive is I have not seen a case where they over promise and under deliver. If I've missed one, someone please point it out. They are pragmatic, focused and moving this battleship across the Atlantic. But it takes time to get to our destination. Not a day or a week but months. Until they show me they are not up to the task, my 5M shares will remain locked with a $1 sales price.

CF